HPV相关口咽癌幸存者重返工作:澳大利亚经验
该横断面单中心研究纳入68例已完成治愈性放疗的HPV相关口咽癌幸存者,中位年龄54.1岁,85.3%正在工作,中位重返工作时间6.0个月;疲劳是主要障碍,休假和治疗医生支持是促进因素。
要点
- 85.3%幸存者重返工作,中位时间6.0个月。
- 疲劳是重返工作的常见障碍。
- 休假与治疗医生支持是促进因素。
核心结论
- 多数HPV相关口咽癌幸存者在放疗后随时间推移重返工作。
- 关注症状管理和工作场所支持可能有助于更成功重返工作。
研究设计与样本
- 在澳大利亚墨尔本Peter MacCallum癌症中心开展的横断面单机构研究。
- 纳入18至65岁、诊断时或诊断前3个月内就业、完成治愈性治疗≥4个月的HPV相关口咽癌幸存者。
- 参与者完成纸质调查评估人口学、就业状态和生活质量,开放性问题探索影响重返工作的因素。
主要发现
- 93例被邀请者中68例回应(73.1%),平均年龄54.1岁(范围39-64岁),89.7%为男性。
- 67.6%为II期疾病,85.3%接受放化疗,治疗后平均时间2.6年(范围0.3-9.1年)。
- 45例(77.6%)从事相同角色,35例(60.3%)工作相同小时数。
- 10例未工作,其中3例退休、5例报告持续显著治疗毒性妨碍就业。
关键数值与推荐
- 重返工作促进因素包括休假可及性和治疗医生的支持。
- 疲劳被频繁报告为重返工作的障碍。
临床怎么用
- 对HPV相关口咽癌幸存者应关注疲劳等治疗相关症状管理以支持重返工作。
- 治疗医生支持和确保休假可及可能促进成功重返工作。
局限性
- 横断面单机构设计,样本量有限(68例回应者)。
- 未报告长期随访或干预性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) commonly affects people of working age, yet there is limited data regarding the return-to-work experience in this cohort. This study aimed to investigate the proportion of survivors currently working after completion of radiation therapy and to explore potential facilitators and barriers to working after treatment. METHODS: A cross-sectional, single-institutional study was undertaken at the Peter MacCallum Cancer Centre, a comprehensive cancer center in Melbourne, Victoria, Australia. Eligible participants were 18 to 65 years old at diagnosis, were employed at or within the 3 months before diagnosis, and had completed curative treatment for HPV-associated OPC ≥4 months before enrollment. Participants completed a paper-based survey to assess baseline demographics, employment status, and quality of life (QOL; Functional Assessment of Cancer Therapy Head and Neck). Open-ended questions explored factors affecting return to work. Associations between current employment status and various disease, treatment, and demographic variables and with QOL were examined. Free-text items were analyzed by summarizing content analysis. RESULTS: Of 93 participants approached, 68 responded (73.1%). Mean age was 54.1 years (range, 39-64 years), and 89.7% were male. Most participants (67.6%) had stage II disease and were treated with chemoradiation (85.3%). Mean time after treatment was 2.6 years (range, 0.3-9.1 years). Fifty-eight of 68 participants (85.3%) were working at enrollment; median time to return to work was 6.0 months (interquartile range, 4-10 months); 45 (77.6%) were in the same role and 35 (60.3%) worked the same number of hours. Ten participants were not working, 3 had retired, 5 reported persistent and significant treatment toxicity preventing employment. Survivors currently working reported higher physical, functional, and global QOL scores. Access to leave and support from treating doctors were facilitators for return to work, whereas fatigue was frequently reported as a barrier to returning to work. CONCLUSION: With time, the majority of participants with HPV-associated OPC will return to work after radiation therapy. Attention to symptom management and support from the workplace may enable more successful return to work.
引用
- Morales CZ, McDowell L, Lisy K, et al. Return to Work in Survivors of Human Papillomavirus-Associated Oropharyngeal Cancer: An Australian Experience. Int J Radiat Oncol Biol Phys. 2019. PMID: 31521718. doi:10.1016/j.ijrobp.2019.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。